EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Efficacy of Percutaneous Image-Guided Ablation in Breast Cancer Metastases to the Liver

Govindarajan Narayanan, Elizabeth Mary Ruiz iD, Madelon Dijkstra iD, Nicole T Gentile, Danielle Donahue, Ripal T Gandhi iD, Reshma L Mahtani, Starr Mautner, Bente A T van den Bemd iD

Cancers · 28.11.2025 · 17 (23) · 3823

DOI: 10.3390/cancers17233823 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 28.11.2025. Verfasst von Govindarajan Narayanan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This single-center retrospective study evaluates the clinical efficacy and safety of percutaneous ablation using microwave ablation (MWA) and irreversible electroporation (IRE) in patients with breast cancer liver metastases (BCLM).

Methods

Between August 2018 and December 2023, 32 patients underwent 40 image-guided ablations for 57 BCLM. Mean age was 61.3 years (range: 32–85), and mean tumor size was 2.9 cm (range: 0.9–7.0 cm). Fifty lesions were treated with MWA and seven with IRE. Clinical efficacy was assessed by m-RECIST response at first follow-up imaging (after ≥1 month) and by monitoring local tumor progression (LTP), local tumor progression-free survival (LTPFS), and overall survival (OS). Safety was evaluated by adverse events according to CTCAE. Kaplan–Meier statistics were used for LTPFS and OS.

Results

Median follow-up was 32.4 months (95% CI 16.6–48.0). Complete response was observed in 34 tumors (59.6%), partial response in 14 (24.6%), and progressive disease in 9 (15.8%). LTP occurred in 37 tumors (64.9%), with a median time to progression of 11.1 months (95% CI 1.4–20.8). One- and two-year LTPFS rates were 43.6% and 34.1%. Sixteen patients died during follow-up, with median OS of 27.8 months (95% CI 19.0–36.6) and 1- and 2-year OS rates of 90.1% and 55.9%. No major complications occurred. Complications included eight Grade 1 and two Grade 2 complications.

Conclusions

Percutaneous ablation demonstrates clinical efficacy and a favorable safety profile in selected BCLM patients, achieving OS comparable to the current literature. Further studies should clarify its additive role within multimodality treatment.

Schlagwörter

Stichwörter der Autor:innen

breast cancer liver metastasesinterventional oncologyirreversible electroporationmicrowave ablation

Autor:innen und Institutionen

  • Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
  • Department of Interventional Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.
  • Department of Interventional Radiology, Miami Cardiac and Vascular Institute, Baptist Health South Florida, Miami, FL 33176, USA.
  • Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location VUmc, Cancer Center Amsterdam, 1081 HV Amsterdam, The Netherlands.
  • Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL 33314, USA.
  • Department of Breast Medical Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.

ORCID-Profile: Elizabeth Mary Ruiz, Madelon Dijkstra, Ripal T Gandhi, Bente A T van den Bemd

Zitieren

APA

Narayanan, G., Ruiz, E. M., Dijkstra, M., Gentile, N. T., Donahue, D., Gandhi, R. T., Mahtani, R. L., Mautner, S., & van den Bemd, B. A. T. (2025). Clinical Efficacy of Percutaneous Image-Guided Ablation in Breast Cancer Metastases to the Liver. Cancers, 17(23), 3823. https://doi.org/10.3390/cancers17233823

Vancouver

Narayanan G, Ruiz EM, Dijkstra M, Gentile NT, Donahue D, Gandhi RT, et al. Clinical Efficacy of Percutaneous Image-Guided Ablation in Breast Cancer Metastases to the Liver. Cancers. 2025;17(23):3823. doi:10.3390/cancers17233823

BibTeX
@article{Narayanan2025,
  author = {Narayanan, Govindarajan and Ruiz, Elizabeth Mary and Dijkstra, Madelon and Gentile, Nicole T and Donahue, Danielle and Gandhi, Ripal T and Mahtani, Reshma L and Mautner, Starr and van den Bemd, Bente A T},
  title = {Clinical Efficacy of Percutaneous Image-Guided Ablation in Breast Cancer Metastases to the Liver},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {23},
  pages = {3823},
  doi = {10.3390/cancers17233823}
}
Kostenlos starten →